Clinical Trial: AI-Assisted Acute Myeloid Leukemia Evaluation With the Leukemia End-to-End Analysis Platform (LEAP) Versus Clinician-Only Assessment

U.S., Oct. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07203885) titled 'AI-Assisted Acute Myeloid Leukemia Evaluation With the Leukemia End-to-End Analysis Platform (LEAP) Versus Clinician-Only Assessment' on Sept. 08.

Brief Summary: This study will test whether artificial intelligence (AI) can help doctors diagnose a rare blood cancer called acute promyelocytic leukemia (APL) more quickly and accurately. Doctors usually examine bone marrow samples under a microscope to make this diagnosis, but it can be challenging and time-consuming.

In this study, doctors will review bone marrow samples under three different conditions:

* Unaided Review: Without AI assistance.

* AI as Double-Check: AI-generated eva...